Riskpilot← Back to searchSign inGet full accessUlrAx Medico Consulting AB
ABActiveOrg 5567504419Köpmansgatan 18 AOther human health activities n.e.c. · NACE 8699Est. 20080 employees
Revenue 2025
SEK 0
EBITDA margin
—
+76% vs 2024
Equity ratio
-1293.3%
Financial strength
Net profit 2025
SEK -27K
+73% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -22K | +76% |
| Net profit | SEK -27K | +73% |
| Total assets | SEK 23K | -22% |
| Equity | SEK -293K | -10% |
| Employees | 0 | — |
Legal name
UlrAx Medico Consulting AB
Org number
5567504419
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
23 januari 2008
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet, projektledning och marknadsföring inom läkemedelsindustrin och därmed förenlig verksamhet.
Address
Köpmansgatan 18 A
Email
ulrika@ulrax.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 51 | 639 | −0 | 0 | 0 |
| Staff expenses | — | −129 | −103 | −1 | −0 |
| EBITDA | −264 | −144 | −408 | −89 | −22 |
| Depreciation & amort. | −0 | — | — | −2 | −2 |
| EBIT | −264 | −144 | −408 | −91 | −24 |
| Net financials | −5 | −10 | −7 | −10 | −4 |
| Profit before tax | −269 | −155 | −415 | −101 | −27 |
| Tax | −0 | — | — | — | — |
| Net profit | −269 | −155 | −415 | −101 | −27 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 334 | 420 | 34 | 29 | 23 |
| Equity | 120 | 100 | −315 | −266 | −293 |
| Long-term debt | 51 | 33 | 52 | 52 | 279 |
| Short-term debt | 163 | 287 | 297 | 243 | 37 |
| Total debt | 214 | 320 | 349 | 295 | 316 |
EBITDA margin
-2181600.0%
This company
15.8%
Market median
-13807695% vs market
20212025
Equity ratio
-1293.3%
This company
38.2%
Market median
-3486% vs market
20212025
Return on equity
-2739500.0%
This company
18.4%
Market median
-14888687% vs market
20212025
Net profit margin
-2739500.0%
This company
8.1%
Market median
-33821088% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MU Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UlrAx Medico Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Ulrika Axelsson | Chief Executive Officer | 0 companies |
| Ida Maria Engelbrektsson | Deputy Board Member | 0 companies |
| Elin Ulrika Engelbrektsson | Deputy Board Member | 0 companies |